等待开盘 08-25 09:30:00 美东时间
+0.370
+3.46%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44
908 Devices shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance.
08-12 01:09
908 Devices (NASDAQ:MASS) raises FY2026 sales outlook from $67.000 million-$70.000 million to $68.000 million-$70.000 million vs $68.585 million estimate.
08-11 19:03
908 Devices (NASDAQ:MASS) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.17) by 88.24 percent. This is a 11.11 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $16.074 million ...
08-11 19:03
今日重点评级关注:古根海姆:维持ProMIS Neurosciences"买入"评级,目标价从35美元升至69美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从38美元升至39美元
07-30 11:45
Roth Capital analyst Max Masucci initiates coverage on 908 Devices (NASDAQ:MASS) with a Buy rating and announces Price Target of $11.
07-29 19:04
手持式化学分析仪器制造商908 Devices Inc.宣布,公司管理层将出席即将举行的Canaccord Genuity第46届年度增长大会,并发表演讲...
07-28 21:01
Shares of electronic equipment, instruments and components stocks are trading l...
06-06 03:11
Shares of companies within the broader technology sector are trading higher ami...
05-29 03:25
Earnings Call Insights: 908 Devices (MASS) Q1 2026 Management View “We entered 2026 from a position of strength with a streamlined cost structure, a solid balance sheet and an expanding recurring reve...
05-07 06:12